What did Integra Lifesciences Holdings Corp. pay for ACell, Inc.?

Integra Lifesciences Holdings Corp. acquired ACell, Inc. for $330.8M in 2021, equivalent to 3.30x revenue. Target revenue was approximately $100.8M.

What does ACell, Inc. do?

ACell, Inc. is a medical devices business.

What multiple did Integra Lifesciences Holdings Corp. pay for ACell, Inc.?

3.30x revenue, based on disclosed deal value of $330.8M and disclosed financials.

M&A TRANSACTION · 2021

ACell, Inc. acquired by Integra Lifesciences Holdings Corp.

$330.8M· 3.30x revenue

Target

ACell, Inc.

Acquirer

Integra Lifesciences Holdings Corp.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$100.8M

EBITDA

—

Deal Value

$330.8M

EV/EBITDA

—

Context

This $330.8M acquisition of ACell, Inc. by Integra Lifesciences Holdings Corp. sits in the medical devices sub-vertical. Integra Lifesciences Holdings Corp. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the ACell, Inc. acquisition.

Citation: ExitValue.ai. (2021). ACell, Inc. acquired by Integra Lifesciences Holdings Corp.. https://exitvalue.ai/deals/acell-inc-acquired-by-integra-lifesciences-holdings-corp-hc-2021-0109